Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling and inflamed skin.
The plaques are common on the scalp, elbows, and knees. Genetic and environmental factors are the most causes of the disease.
The U.S. Food and Drug Administration FDAhas approved Tremfya (guselkumab), an interleukin-23 blocker for the treatment of adult patients with moderate-to-severe plaque psoriasis.
Tremfya is a medicine that may lower the ability of immune system to fight infections and may increase risk of infections.
Tremfya is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills.
Common side effects of this drug are:
upper respiratory infections, joint pain,
fungal skin infections, headache and diarrhea.
haleplushearty.blogspot.com
No comments:
Post a Comment